Abstract:Background: As a key component in the NOTCH signaling pathway, HES1 plays an important role in vertebrate heart development. Variants in the HES1 coding sequence are known to be associated with congenital heart disease (CHD). However, little is known about HES1 non-coding sequence variants and their association with the risk of developing CHD.Method and Results: We initially analyzed the non-coding sequence of the HES1 gene in 12 unrelated CHD families by direct sequencing and identified a previously unreported promoter region variant (NM_005524.4: c.−1279−1278 insAC, rs148941464) in the HES1 gene in four CHD families. The homozygous variant in patients was inherited from carrier parents with normal phenotypes, indicating a likely recessive genetic model. Given that the HES1 gene is predicted to be likely to exhibit haploinsufficiency (%HI: 11.44), we hypothesized that the HES1 homozygous variant is a genetic risk factor underlying CHD. We then carried out sequencing of this HES1 variant in 629 sporadic non-syndromic CHD cases and 696 healthy controls and performed association analysis. Interestingly, we observed a significant association of the homozygous HES1 promoter variant with CHD (18.92% of cases vs. 9.91% of controls; OR: 2.291, 95% CI: 1.637-3.207, p = 9.72 × 10−7). No significant association with CHD was observed for the HES1 promoter heterozygous variant (p > 0.05). However, association analysis tests of the HES1 homozygous variant with each subtype of CHD revealed that this homozygous variant was strongly associated with transposition of the great arteries (TGA) (OR: 3.726, 95% CI: 1.745-7.956, p = 0.0003). Moreover, the prevalence of HES1 homozygous variants in CHD patients with TGA (27.66%) was significantly higher than that in patients with other CHD subtypes or controls. Similar results were observed in a replication group of TGA (n = 64). Functional studies demonstrated that the homozygous variant in the HES1 promoter can disrupt its ability to bind RXRA, an inhibitory transcription factor, which results in abnormally high expression of the HES1 gene, indicating that this variant harbors gain-of-function effects.Conclusions: Our findings reveal that the non-coding homozygous variant in the HES1 promoter has a gain-of-function effect and is associated with an increased risk of CHD development, especially the severe TGA subtype.

Novel and deleterious nucleotide variations in the HAND1 gene probably affect miRNA target sites and protein function in pediatric patients with congenital heart disease

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

Identification Of Novel Single-Nucleotide Variants With Potential Of Mediating Malfunction Of Microrna In Congenital Heart Disease

HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy.

HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Long Non-Coding RNA SAP30-2:1 is Downregulated in Congenital Heart Disease and Regulates Cell Proliferation by Targeting HAND2

DNAH11 Variants and Its Association with Congenital Heart Disease and Heterotaxy Syndrome

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

Molecular and cellular role of variants of the promoter region of HAND1 gene in sporadic and isolated ventricular septal defect

A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population.

A Non-coding HES1 Variant Predisposes Children to Congenital Heart Disease in Chinese Population

Identification and Genetic Analysis of Rare Variants in Myosin Family Genes in 412 Han Chinese Congenital Heart Disease Patients.

A Novel NR2F2 Loss-of-function Mutation Predisposes to Congenital Heart Defect.

Deleterious Rare Mutations of GLI1 Dysregulate Sonic Hedgehog Signaling in Human Congenital Heart Disease

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Association of Genetic Polymorphisms of De Novo Nucleotide Biosynthesis with Increased Chd Susceptibility in the Northern Chinese Population

[Association Between Nuclear Factor of Activated T Cells 1 Gene Mutation and Simple Congenital Heart Disease in Children].

An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations

A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle